PET/CT of fibrodysplasia ossificans progressiva

被引:7
|
作者
Kulwin, Robert [1 ]
Binkovitz, Larry A. [1 ]
机构
[1] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH 43205 USA
关键词
Fibrodysplasia; Ossificans; FDG PET; Heterotopic ossification; Child; INJECTION;
D O I
10.1007/s00247-009-1281-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Fibrodysplasia ossificans progressiva (FOP) is an exceedingly rare genetic disorder of connective tissue characterized by extensive and irreversible heterotopic ossification of soft-tissue masses that develop in response to inflammation or trauma. Successful management relies on preventative measures and avoidance of invasive procedures such as intramuscular injections and biopsies. Early diagnosis can prevent extensive heterotopic ossification and is possible with recognition of the classic clinical findings in the feet in association with rapidly evolving soft-tissue masses of the trunk and extremities. Unfortunately, in 87% of the 269 previously reported cases, the diagnosis was not considered initially. Patients are often subjected to biopsy of the soft-tissue masses. The pathology of the fibrodysplasia ossificans progressiva is often confused with sarcoma. These patients might be imaged with PET as part of a standard oncological work-up. We present the first reported PET/CT images of a patient with FOP in order to alert radiologists to this diagnostic pathway. Awareness of the disorder might prevent further unnecessary interventions that can lead to extensive deformity and suffering.
引用
收藏
页码:991 / 994
页数:4
相关论文
共 50 条
  • [21] Challenges in the treatment of fibrodysplasia ossificans progressiva
    Kardelen Gencer-Atalay
    Ekim Can Ozturk
    Ilker Yagci
    Pinar Ata
    Kenan Delil
    Zerrin Ozgen
    Gulseren Akyuz
    Rheumatology International, 2019, 39 : 569 - 576
  • [22] Fibrodysplasia Ossificans Progressiva: A Case Report
    Qi, Linzeng
    Guo, Yongyuan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [23] Fibrodysplasia ossificans progressiva -: Case report
    Gonçalves, AL
    Masruha, MR
    de Campos, CC
    Delai, PLR
    Vilanova, LCP
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2005, 63 (04) : 1090 - 1093
  • [24] Challenges in the treatment of fibrodysplasia ossificans progressiva
    Gencer-Atalay, Kardelen
    Ozturk, Ekim Can
    Yagci, Ilker
    Ata, Pinar
    Delil, Kenan
    Ozgen, Zerrin
    Akyuz, Gulseren
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (03) : 569 - 576
  • [25] Evolving Management of Fibrodysplasia Ossificans Progressiva
    Kannu, Peter
    Levy, Charles E.
    JOURNAL OF PEDIATRICS, 2021, 232 : S9 - S15
  • [26] Animal models of fibrodysplasia ossificans progressiva
    Kaplan F.S.
    Shore E.M.
    Pignolo R.J.
    Glaser D.L.
    Clinical Reviews in Bone and Mineral Metabolism, 2005, 3 (3-4): : 229 - 234
  • [27] Early diagnosis of fibrodysplasia ossificans progressiva
    Kaplan, Frederick S.
    Xu, Meiqi
    Glaser, David L.
    Collins, Felicity
    Connor, Michael
    Kitterman, Joseph
    Sillence, David
    Zackai, Elaine
    Ravitsky, Vardit
    Zasloff, Michael
    Ganguly, Arupa
    Shore, Eileen M.
    PEDIATRICS, 2008, 121 (05) : E1295 - E1300
  • [28] Recent Topics in Fibrodysplasia Ossificans Progressiva
    Katagiri, Takenobu
    Tsukamoto, Sho
    Nakachi, Yutaka
    Kuratani, Mai
    ENDOCRINOLOGY AND METABOLISM, 2018, 33 (03) : 331 - 338
  • [29] Fibrodysplasia ossificans progressiva as a form of pseudodystonia
    Dulski, Jaroslaw
    Slawek, Jaroslaw
    PARKINSONISM & RELATED DISORDERS, 2020, 77 : 180 - 181
  • [30] Immunologic Aspects in Fibrodysplasia Ossificans Progressiva
    Diolintzi, Anastasia
    Pervin, Mst Shaela
    Hsiao, Edward C.
    BIOMOLECULES, 2024, 14 (03)